Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Enzymatic determination of total serum cholesterol.

Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845

Detection of circulating tumor necrosis factor after endotoxin administration

Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677

Cachectin: More Than a Tumor Necrosis Factor

Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,423

A colorimetric method for estimating serum triglycerides

Fletcher, M. J. (1968) · Clinica Chimica Acta · doi:10.1016/0009-8981(68)90041-7 · Cited by 1,133

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

Lähdevirta, J., Maury, C. P. J., Teppo, A., & Repo, H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90576-1 · Cited by 717

Tumour necrosis factors α and β inhibit virus replication and synergize with interferons

Wong, G. H., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 707

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

Schüpbach, J., Popovič, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200937 · Cited by 610

Cytokine appearance in human endotoxemia and primate bacteremia.

HESSE, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Cerami, A., Shires, G. T., & Lowry, S. F. (1988) · PubMed · Cited by 532

The Acquired Immunodeficiency Syndrome

Gottlieb, M. S., Groopman, J. E., WEINSTEIN, W. M., FAHEY, J. L., & DETELS, R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-208 · Cited by 471

Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon

Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., & Vilček, J. (1982) · Science · doi:10.1126/science.6176024 · Cited by 458

Serum lipid profile in highly active antiretroviral therapy‐naïve HIV‐infected patients in Cameroon: a case–control study

Nguemaim, N. F., Mbuagbaw, J. C., Nkoa, T., Alemnji, G. A., Teto, G., Fanhi, T., Asonganyi, T., & Samé‐Ekobo, A. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00784.x · Cited by 42

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

Rodriguez‐Torres, M., Govindarajan, S., Sola, R. L., Clumeck, N., Lissen, E., Pessôa, M. G., Buggisch, P., Main, J., DePamphilis, J. K., & Dieterich, D. T. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.015 · Cited by 41

Nutrition and the HIV-associated lipodystrophy syndrome

Loonam, C., & Mullen, A. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422411000138 · Cited by 40

Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M

Liu, J., Streiff, R. J., Zhang, Y. L., Vestal, R. E., Spence, M. J., & Briggs, M. R. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37134-0 · Cited by 40

Nutrition: A cofactor in HIV disease

Timbo, B. B., & Tollefson, L. (1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92196-2 · Cited by 40

Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders

Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40

From Wasting to Obesity, Changes in Nutritional Concerns in HIV/AIDS

Mankal, P. K., & Kotler, D. P. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.05.004 · Cited by 39

Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998

Thiébaut, R., Dabis, F., Malvy, D. J.-M., Jacqmin‐Gadda, H., Mercié, P., & Valentin, V. D. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200003010-00009 · Cited by 39

TISSUE WASTING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, THE ACQUIRED IMMUNE DEFICIENCY SYNDROME, AND CONGESTIVE HEART FAILURE

Farber, M. O., & Mannix, E. T. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70188-2 · Cited by 38

Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Khovidhunkit, W., Memon, R. A., Shigenaga, J. K., Pang, M., Schambelan, M., Mulligan, K. M., Feingold, K. R., & Grünfeld, C. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90240-8 · Cited by 37

Transferrin, Iron, and Serum Lipids Enhance or Inhibit Mycobacterium avium Replication in Human Macrophages

Douvas, G. S., May, M. H., & Crowle, A. J. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.857 · Cited by 37

Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome

Grünfeld, C., Doerrler, W. T., Pang, M., Jensen, P., Weisgraber, K. H., & Feingold, K. R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4366 · Cited by 37

Role of cytokines in AIDS wasting

Chang, H. R., Dulloo, A. G., & Bistrian, B. R. (1998) · Nutrition · doi:10.1016/s0899-9007(98)00108-7 · Cited by 35

Metabolic Consequences of Antiretroviral Therapy

Diggins, C. E., Russo, S. C., & Lo, J. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00600-6 · Cited by 36

HIV Wasting Syndrome: Treatment Update

Balog, D. L., Epstein, M. E., & Amodio-Groton, M. I. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17072 · Cited by 36

Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons

Berman, B., Flores, F., & Burke, G. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70159-8 · Cited by 35

4 The syndrome of acquired glucocorticoid resistance in HIV infection

Norbiato, G., Galli, M., Righini, V., & Moroni, M. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80300-3 · Cited by 34

Nutritional Effects and Support in the Patient with Acquired Immunodeficiency Syndrome ,

Kotler, D. P. (1992) · Journal of Nutrition · doi:10.1093/jn/122.suppl_3.723 · Cited by 33

1 Aetiology and pathogenesis of hormonal and metabolic disorders in HIV infection

Grinspoon, S. K., Donovan, D. S., & Bilezikian, J. P. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80297-6 · Cited by 33

Lipodystrophy in HIV patients: its challenges and management approaches

Kotler, D. P., & Singhania, R. (2011) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s14562 · Cited by 32

The effects of HIV protease inhibitors on carbohydrate and lipid metabolism

Lee, G. A., Rao, M. N., & Grünfeld, C. (2004) · Current Infectious Disease Reports · doi:10.1007/s11908-004-0067-5 · Cited by 32

Regulation of chemokine/cytokine network during in vitro differentiation and HIV-1 infection of human monocytes: possible importance in the pathogenesis of AIDS

Fantuzzi, L., Conti, L., Gauzzi, M. C., Eid, P., Cornò, M. D., Varano, B., Canini, I., Belardelli, F., & Gessani, S. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.3.391 · Cited by 32

Coronary heart disease associated with the use of human immunodeficiency virus (HTV)‐1 protease inhibitors: Report of four cases and review

Duong, M., Buisson, M., Cottin, Y., Piroth, L., L’Huillier, I., Grappin, M., Chavanet, P., Wolff, J., & Portier, H. (2001) · Clinical Cardiology · doi:10.1002/clc.4960241011 · Cited by 32

Induction of CD83+CD14+ Nondendritic Antigen-Presenting Cells by Exposure of Monocytes to IFN-α

Gerlini, G., Mariotti, G., Chiarugi, A., Gennaro, P. D., Caporale, R., Parenti, A., Cavone, L., Tun-Kyi, A., Prignano, F., Saccardi, R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2999 · Cited by 31

De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting

Hoh, R., Pelfini, A., Neese, R. A., Chan, M. F., Cello, J. P., Cope, F. O., Abbruzzese, B. C., Richards, E. W., Courtney, K., & Hellerstein, M. K. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.1.154 · Cited by 31

Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection.

Moyle, G. J., Moutschen, M. P., Martínez, E., Domingo, P., Guaraldi, G., Raffi, F., Behrens, G. M. N., & Reiss, P. (2010) · PubMed · Cited by 30

Body Composition and Nutritional Parameters in HIV and AIDS Patients

Salomon, J., de Truchis, P., & Melchior, J. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.229 · Cited by 30

Endotoxin, Cytokines, and Hyperlipidemia

Liao, W., & Florén, C. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309096053 · Cited by 30

X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology

Purtilo, D. T. (1991) · Springer Seminars in Immunopathology · doi:10.1007/bf00201468 · Cited by 30

Carotid intima–media thickness in HIV patients treated with antiretroviral therapy

Lebech, A., Wiinberg, N., Kristoffersen, U. S., Hesse, B., Petersen, C. L., Gerstoft, J., & Kjær, A. (2007) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2007.00737.x · Cited by 29

ENDOCRINOLOGIC COMPLICATIONS OF HIV INFECTION

Danoff, A. (1996) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70498-3 · Cited by 29

Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients

Vecchi, V. L., Giannitrapani, L., Carlo, P. D., Mazzola, G. C., Colletti, P., Spada, E. L., Vizzini, G. B., Montalto, G., & Soresi, M. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31315-8 · Cited by 27

Glucocorticoid Resistance and the Immune Function in the Immunodeficiency Syndrome

Norbiato, G., Bevilacqua, M. T., Vago, T., & Clerici, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09621.x · Cited by 27

Glucocorticoids and the immune system in AIDS

Norbiato, G., Bevilacqua, M., & Vago, T. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00011-5 · Cited by 27

Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice.

Browning, P. J., Roberts, D. D., Zabrenetzky, V. S., Bryant, J., Kaplan, M. P., Washington, R., Panet, A., Gallo, R. C., & Vogel, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1949 · Cited by 27

Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression

Liao, W., Rudling, M., & Angelin, B. (1996) · Biochemical Journal · doi:10.1042/bj3130873 · Cited by 26

Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia

Lebech, A., Kristoffersen, U. S., Wiinberg, N., Kofoed, K., Andersen, O., Hesse, B., Petersen, C. L., Gerstoft, J., & Kjær, A. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0846-6 · Cited by 25

Dietary Fat Alters HIV Protease Inhibitor–Induced Metabolic Changes in Mice

Lenhard, J. M., Croom, D. K., Weiel, J. E., Spaltenstein, A., Reynolds, D. J., & Furfine, E. S. (2000) · Journal of Nutrition · doi:10.1093/jn/130.9.2361 · Cited by 25

Dyslipidaemia and cardiovascular risk in HIV infection

Kulasegaram, R., Peters, B. S., & Wierzbicki, A. S. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x65529 · Cited by 25

HIV and Global Cardiovascular Health

Wagle, A. A., Goerlich, E., Post, W. S., Woldu, B., Wu, K. C., & Hays, A. G. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01741-1 · Cited by 24

The prevalence of HIV among patients admitted with stroke at the Muhimbili National Hospital, Dar es Salaam, Tanzania

Mlay, M. G., & Bakari, M. (2010) · Tanzania journal of health research/Tanzania Journal of Health Research · doi:10.4314/thrb.v12i2.56397 · Cited by 24

Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression

Marín-Palma, D., Castro, G. A., Cardona‐Arias, J. A., Inchima, S. U., & Hernández, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01350 · Cited by 24

Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!

van Leuven, S. I., Sankatsing, R. R., Vermeulen, J. N., Kastelein, J. J. P., Reiss, P., & Stroes, E. S. G. (2007) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3281e38a98 · Cited by 23

Lipid and acute-phase protein alterations in HIV-1 infected patients in the early stages of infection: correlation with CD4+ lymphocytes

Treitinger, A., Spada, C., da Silva, L. M. D., Hermes, E. M., Amaral, J. A., & Abdalla, D. S. P. (2001) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702001000400005 · Cited by 23

A new multifunctional hydroxytyrosol-fenofibrate with antidiabetic, antihyperlipidemic, antioxidant and antiinflammatory action

Xie, Y., Xu, Y.-H., Chen, Z., Lu, W.-F., Li, N., Wang, Q., Shao, L., Li, Y., Yang, G., & Bian, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.073 · Cited by 23

Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review

Souza, S. J., Luzia, L. A., dos Santos, S. D. S., & Rondó, P. H. D. C. (2013) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(13)70454-5 · Cited by 23

Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996–99

Thiébaut, R., Dequae-Merchadou, L., Ekouévi, D. K., Mercié, P., Malvy, D. J.-M., Neau, D., Dabis, F., & (gec, T. G. D. C. S. E. A. (2001) · HIV Medicine · doi:10.1046/j.1468-1293.2001.00057.x · Cited by 23

Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia

Yarasheski, K. E., Tebas, P., Claxton, S., Marin, D., Coleman, T., Powderly, W. G., & Semenkovich, C. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00036.2003 · Cited by 23

Lipid profiles associated with antiretroviral drug choices

van der Valk, M., & Reiss, P. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200302000-00004 · Cited by 23

Changes in Blood Lipid Composition and Response to Interferon Treatment in Chronic Hepatitis C

Soardo, G., Pirisi, M., Fonda, M., Fabris, C., Falleti, E., Toniutto, P., Vitulli, D., Cattin, L., Gonano, F., & Bartoli, E. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.705 · Cited by 23

Staphylococcus aureus carriage and HIV-1 disease: association with increased mucocutaneous infections as well as deep soft-tissue infections and sepsis

Smith, K. J. (1994) · Archives of Dermatology · doi:10.1001/archderm.130.4.521 · Cited by 22

Macrophages, cytokines, and HIV

Bornemann, M. A. C., Verhoef, J., & Peterson, P. K. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90156-6 · Cited by 22

Histologically Distinctive Papular Neutrophilic Xanthomas in HIV-1+ Patients

Smith, K. J., Yeager, J. K., & Skelton, H. G. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199705000-00006 · Cited by 21

The management of dyslipidaemias in antiretroviral‐treated HIV infection: a systematic review

McGoldrick, C., & Leen, C. L. S. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00480.x · Cited by 21

HIV-associated Lipodystrophy Syndrome: Description and Pathogenesis

Bodasing, N., & Fox, R. (2003) · Journal of Infection · doi:10.1053/jinf.2002.1102 · Cited by 21

Abnormal lipids and the acquired immunodeficiency syndrome: is there a problem and what should we do about it?

Crook, M. A., & Mir, N. (1999) · International Journal of STD & AIDS · doi:10.1177/095646249901000601 · Cited by 20

Nutrition and HIV infection

Gramlich, L. M., & Mascioli, E. A. (1995) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(94)00001-3 · Cited by 20

Pathogenesis of cardiovascular disease in HIV infection

Carr, A. D. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282fb7be0 · Cited by 20

Hypertriglyceridemia may be severe in CML patients treated with interferon‐α

Peñarrubia, M. J., Steegmann, J. L., Lavilla, E., Casado, F., Requena, M. J., Picó, M., Arranz, R., & Fernández‐Rañada, J. M. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830490311 · Cited by 19

Lipid Abnormalities

Dubé, M. P., & Fenton, M. (2003) · Clinical Infectious Diseases · doi:10.1086/367562 · Cited by 19

Prevalence of hypertension and cardiovascular risk factors among long‐term AIDS survivors: A report from the field

Pierre, S., Seo, G. Z., Rivera, V. R., Walsh, K. F., Victor, J. J., Charles, B., Julmiste, G., Dumont, E. D., Apollon, A., Cadet, M., et al. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13663 · Cited by 18

Ketotifen in HIV-infected patients: effects on body weight and release of TNF-α

Ockenga, J., Rohde, F., Süttmann, U., Herbarth, L., Ballmaier, M., & Schedel, I. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050087 · Cited by 18

Coronary heart disease in HIV-infected patients

Glesby, M. J. (2005) · Current HIV/AIDS Reports · doi:10.1007/s11904-005-0021-7 · Cited by 18

Body Composition Studies in HIV‐Infected Individuals

Kotler, D. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06514.x · Cited by 18

Hypoalbuminemia in Dialysis Patients

Kaysen, G. A. (1996) · Seminars in Dialysis · doi:10.1111/j.1525-139x.1996.tb00664.x · Cited by 18

Clinical Management and Follow-up of Hypercholesterolemia Among Perinatally HIV-Infected Children Enrolled in the PACTG 219C Study

Jacobson, D. L., Williams, P. L., Tassiopoulos, K., Melvin, A. J., Hazra, R., & Farley, J. J. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31822203f5 · Cited by 17

Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: A need for more mechanistic studies and large, randomized, placebo-controlled trials

Foo, J., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.04.013 · Cited by 17

The metabolic puzzle during the evolution of HIV infection

Salas‐Salvadó, J., & García‐Lorda, P. (2001) · Clinical Nutrition · doi:10.1054/clnu.2001.0429 · Cited by 17

Regulation and Characterization of the Interferon-α Present in Patients with Advanced Human Immunodeficiency Virus Type 1 Disease

Swindells, S., Baldwin, T., Kelly, C., Baca, L. M., Loomis, L., Post, D. J., Břicháček, B., Stevenson, M., Dominguez, E. A., Reddy, R. L., et al. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.127 · Cited by 16

Aerobic Exercise Training Fails to Lower Hypertriglyceridemia Levels in Persons With Advanced HIV-1 Infection

Birk, T. J., MacArthur, R. D., Lipton, L. M., & Levine, S. (2002) · Journal of the Association of Nurses in AIDS Care · doi:10.1177/1055329002238022 · Cited by 16

Different Isoforms of Apolipoprotein AI Present Heterologous Post-Translational Expression in HIV Infected Patients

Kim, S.-S., Kim, M.-H., Shin, B., Na, H.-J., Choi, J., Kee, M., Chong, S.-A., & Nam, M. (2006) · Journal of Proteome Research · doi:10.1021/pr060323f · Cited by 16

Human immunodeficiency virus infection, Part I

Horowitz, H. W., Telzak, E. E., Sepkowitz, K. A., & Wormser, G. P. (1998) · Disease-a-Month · doi:10.1016/s0011-5029(98)90014-1 · Cited by 16

The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism

de Almeida, E. R. D., Reiche, E. M. V., Kallaur, A. P., Flauzino, T., & Watanabe, M. A. E. (2013) · BioMed Research International · doi:10.1155/2013/836790 · Cited by 16

1,3-Benzodioxole-based fibrate derivatives as potential hypolipidemic and hepatoprotective agents

Xie, Y., Xu, Y.-H., Liu, J.-P., Wang, B., Shi, Y., Wang, W., Wang, X., Sun, M., Xu, X., & Bian, X. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127898 · Cited by 15

HIV and metabolic syndrome in an Ethiopian population

Møller, S. P., Amare, H., Christensen, D. L., Yilma, D., Abdissa, A., Friis, H., Faurholt‐Jepsen, D., & Olsen, M. F. (2020) · Annals of Human Biology · doi:10.1080/03014460.2020.1781929 · Cited by 14

Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.

Hiransuthikul, N., Hiransuthikul, P., & Kanasook, Y. (2007) · PubMed · Cited by 14

Influence of Hepatitis C Genotypes on Lipid Levels in HIV-Positive Patients during Highly Active Antiretroviral Therapy

Lapadula, G., Torti, C., Paraninfo, G., Castelnuovo, F., Uccelli, M. C., Costarelli, S., Ladisa, N., Maserati, R., Pietro, M. D., Silvestri, A. D., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100405 · Cited by 14

Alpha-Tocopherol and NADPH in the Erythrocytes and Plasma of Multiple Sclerosis Patients

Karg, E., Klivènyi, P., Bencsik, K., Túri, S., & Vécsei, L. (2003) · European Neurology · doi:10.1159/000073862 · Cited by 13

HIV infection and lipodystrophy

Kotler, D. P. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.2 · Cited by 13

Nutritional assessment of vitamin E in malnourished patients with AIDS

Monteiro, J. P., da Cunha, D. F., da Cunha, S. F. D. C., dos Santos, V. M., Jordão, A. A., Correia, D., Silva-Vergara, M. L., Vannucchi, H., Júnior, V. R., & Bianchi, M. D. L. P. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00227-6 · Cited by 13

Aids: Part II

Kessler, H. A., Bick, J. A., Pottage, J. C., & Benson, C. A. (1992) · Disease-a-Month · doi:10.1016/0011-5029(92)90027-m · Cited by 13

Hypertriglyceridemia during Long-Term Interferon-Alpha Therapy: Efficacy of Diet and Gemfibrosil Treatment. A Case Report

Berruti, A., Gorzegno, G., Vitetta, G., Tampellini, M., & Dogliotti, L. (1992) · Tumori Journal · doi:10.1177/030089169207800515 · Cited by 13

Nutrition support and the human immunodeficiency virus (HIV)

Bell, S., Mascioli, E., Forse, R., & Bistrian, B. (1993) · Parasitology · doi:10.1017/s0031182000075508 · Cited by 16

Dyslipidemia and its Correlates among HIV Infected Children on HAART Attending Mbarara Regional Referral Hospital

Nampijja, D. (2017) · International Clinical Pathology Journal · doi:10.15406/icpjl.2017.04.00098 · Cited by 12

Changes in CD4+ cell count, lipid profile and liver enzymes in HIV infection and AIDS patients

Pasupathi, P., Bakthavathsalam, G., Saravanan, G., & Devaraj, A. (2008) · Journal of Applied Biomedicine · doi:10.32725/jab.2008.017 · Cited by 12

New Options in the Treatment of Lipid Disorders in HIV-Infected Patients

da Silva, É. F. R., & Bárbaro, G. (2009) · The Open AIDS Journal · doi:10.2174/1874613600903010031 · Cited by 12

Hormonal Contraception and HIV‐Positive Women: Metabolic Concerns and Management Strategies

Womack, J. A., Richman, S. M., Tien, P. C., Grey, M. J., & Williams, A. B. (2008) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2008.01.006 · Cited by 11

Altered Mitogen-Activated Protein Kinase Signal Transduction in Human Skin Fibroblasts During In Vitro Aging: Differential Expression of Low-Density Lipoprotein Receptor

Bose, C., Bhuvaneswaran, C., & Udupa, K. B. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.2.b126 · Cited by 11

Hypertriglyceridemia During Long-Term Interferon-α Therapy in a Series of Hematologic Patients

Sgarabotto, D., Vianello, F., Stefani, P. M., Scano, F., SARTORI, R., Caenazzo, A., & Girolami, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.241 · Cited by 11

Phase I/II Trial of the Type I Soluble Recombinant Human Interleukin-1 Receptor in HIV-1-Infected Patients

Takebe, N., Paredes, J., PINO, M. C., LOWNSBURY, W. H., Agosti, J. M., & Krown, S. E. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.321 · Cited by 11

Lipids and atherosclerosis

Halpern, M. J. (1995) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(95)00004-6 · Cited by 11

The relationship of serum total sialic acid with serum acute phase proteins and lipoprotein (a) in patients with severe hypertriglyceridaemia

Crook, M. A., Haq, S., Haq, M. Z. U., & Tutt, P. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00985.x · Cited by 11

Management of HIV-Related Bodyweight Loss

Roenn, J. H. V. (1994) · Drugs · doi:10.2165/00003495-199447050-00005 · Cited by 11

Incidence and risk factors of hypertriglyceridemia in males with human immunodeficiency virus who are treated with combination antiretroviral therapy: a retrospective cohort study

Yu, X.-D., Huang, H., Jiao, Y., Li, J., Fan, X., Zhang, D., & Wang, F. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01786-3 · Cited by 10

Tumor Necrosis Factor, Interleukin-6,and Epinephrine Are Associated with Hypermet abolism in AIDS Patients with Acute Opportunistic Infections

Süttmann, U., Holtmannspötter, M., Ockenga, J., Gallati, H., Deicher, H., & Selberg, O. (2000) · Annals of Nutrition and Metabolism · doi:10.1159/000012820 · Cited by 10

Interferon‐α Signalling in Bovine Adrenal Chromaffin Cells: Involvement of Signal‐Transducer and Activator of Transcription 1 and 2, Extracellular Signal‐Regulated Protein Kinases 1/2 and Serine 31 Phosphorylation of Tyrosine Hydroxylase

Douglas, S. A., & Bunn, S. J. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01821.x · Cited by 10

High frequency of Fredrickson's phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus

Albuquerque, E. M., de Faria, E. C., Oliveira, H. C. F., Magro, D. O., & Castilho, L. N. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-47 · Cited by 10

Lipolytic sensitivity to catecholamines in patients with human immunodeficiency virus infection

Heijligenberg, R., Romijn, J. A., Klein, S., Endert, E., & Sauerwein, H. P. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.3.633 · Cited by 10

Nutritional Deficiencies in AIDS PatientsA Treatment Opportunity

LEE, J. (2002) · Elsevier eBooks · doi:10.1016/b978-0-443-05831-8.50012-6 · Cited by 10

Interferon Alpha 2A in the Treatment of Chronic Myelogenous Leukemia in Chronic Phase. Results of the Spanish Group

Fernandez-Rañada, J. M., Lavilla, E., Odriozola, J., García‐Laraña, J., Lozano, M. L., Parody, R., Mp, G., Carbonell, F., Ferrò, M. T., & Steegmann, J. L. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309047882 · Cited by 10

The Role of the Cytokines, Interferon Alpha and Tumor Necrosis Factor in the Hypertriglyceridemia and Wasting of AIDS ,

Grünfeld, C., & Feingold, K. R. (1992) · Journal of Nutrition · doi:10.1093/jn/122.suppl_3.749 · Cited by 71

Hypertriglyceridemia in the acquired immunodeficiency syndrome

Grünfeld, C., Kotler, D. P., Hamadeh, R., Tierney, A. R., Wang, J., & Pierson, R. N. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90225-8 · Cited by 436

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Grünfeld, C., Pang, M., Doerrler, W. T., Shigenaga, J. K., Jensen, P., & Feingold, K. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1373735 · Cited by 845

Increased serum interferon alpha in HIV–1 associated lipodystrophy syndrome

Christeff, N., Melchior, J., de Truchis, P., Perronne, C., & Gougeon, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.0014-2972.2001.00940.x · Cited by 57

Interféron et facteur de nécrose tumorale sériques chez 95 patients infectés par le VIH

Constans, J., Pellegrin, J., Pellegrin, I., Peuchant, E., Dumon, M. F., Sergeant, C., Simonoff, M., Brossard, G., Barbeau, P., Clerc, M., et al. (1993) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)80122-5 · Cited by 1